770 cancer patients join study to unlock immunotherapy secrets

NCT ID NCT03514368

Recruiting now Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 770 adults with advanced solid cancers (like lung, head and neck, melanoma, or bladder cancer) who are receiving immunotherapy. Researchers collect tumor and blood samples over time to find biological markers that predict how well the treatment works or causes side effects. The goal is to learn, not to test a new treatment, so participants continue their regular care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer head and neck cancer melanoma neoplasm non-small cell lung carcinoma urinary bladder carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID CANCERS

Contacts and locations

Locations

Chu Rangueil
RECRUITING

Toulouse, France
Hopital Larrey
RECRUITING

Toulouse, 31059, France
Institut Universitaire Du Cancer de Toulouse - Oncopole
RECRUITING

Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.